These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2308477)

  • 21. Serological diagnosis of chronic delta infection: correlation between serological markers and hepatitis delta virus RNA in hepatic tissue.
    Buti M; Lopez-Talavera JC; Allende H; Jardi R; Esteban R; Guardia J
    Prog Clin Biol Res; 1993; 382():319-23. PubMed ID: 8502697
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.
    Thomas HC; Farci P; Shein R; Karayiannis P; Smedile A; Caruso L; Gerin J
    Prog Clin Biol Res; 1987; 234():277-90. PubMed ID: 3628382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of hepatitis D virus infection in Japanese patients with hepatocellular carcinoma--immunohistochemical investigation of the delta antigen.
    Kage M; Kosai K; Shimamatsu K; Nakashima O; Haramaki M; Yasunaga M; Iha H; Kojiro M; Govindarajan S
    Kurume Med J; 1992; 39(4):231-4. PubMed ID: 1339069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of delta hepatitis in Switzerland.
    Gudat FG; Bianchi L; Stalder GA; Schmid M
    Prog Clin Biol Res; 1987; 234():431-2. PubMed ID: 3628405
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of delta antigen/antibody in various HBsAg positive patients in Saudi Arabia.
    Shobokshi OA; Serebour FE
    Prog Clin Biol Res; 1987; 234():471-5. PubMed ID: 2819896
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: immunopathologic and serologic findings.
    Lee SD; Wang JY; Wu JC; Tsai YT; Lo KJ; Lai KH; Tsay SH; Govindarajan S
    Scand J Infect Dis; 1987; 19(2):173-7. PubMed ID: 3616486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta viral replication markers in acute and chronic D infection.
    Buti M
    Prog Clin Biol Res; 1991; 364():201-5. PubMed ID: 2020696
    [No Abstract]   [Full Text] [Related]  

  • 28. Tubular structures in the hepatic nuclei of a patient with delta agent.
    Yamada G; Manabe K; Nagashima H
    Acta Med Okayama; 1986 Aug; 40(4):225-8. PubMed ID: 3766206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 30. [Delta virus superinfection in a patient with chronic viral hepatitis B].
    Decker T; Baumgarten R; Roschlau G
    Zentralbl Allg Pathol; 1986; 132(4):283-8. PubMed ID: 3541449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental infection of chimpanzees with the HBsAg-associated delta (delta) agent: an ultrastructural study.
    Canese MG; Rizzetto M; Novara R; London WT; Purcell RH
    J Med Virol; 1984; 13(1):63-72. PubMed ID: 6420512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy of chronic delta hepatitis with alpha- and beta-interferon.
    Gaudin JL; Trépo C
    Prog Clin Biol Res; 1993; 382():345-52. PubMed ID: 8502701
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation of serum anti-delta with intrahepatic HBV and HDV antigens in patients with chronic active hepatitis.
    Caporaso N; Di Sapio M; Del Vecchio-Blanco C; Coltorti M
    Prog Clin Biol Res; 1987; 234():137-44. PubMed ID: 3628372
    [No Abstract]   [Full Text] [Related]  

  • 34. Delta-virus hepatitis.
    Thaler H
    Tokai J Exp Clin Med; 1985 Apr; 10(1):1-3. PubMed ID: 4095710
    [No Abstract]   [Full Text] [Related]  

  • 35. Intrahepatic markers of hepatitis delta virus infection: a study by in situ hybridization.
    Negro F; Bonino F; Di Bisceglie A; Hoofnagle JH; Gerin JL
    Hepatology; 1989 Dec; 10(6):916-20. PubMed ID: 2684838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the presence of two forms of delta antigen in liver tissues of acute versus chronic delta hepatitis.
    Govindarajan S; Hwang S; Lai MM
    Prog Clin Biol Res; 1993; 382():139-43. PubMed ID: 8502671
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of chronic delta hepatitis with recombinant human alpha interferon.
    Hoofnagle J; Mullen K; Peters M; Avigan M; Park Y; Waggoner J; Gerin J; Hoyer B; Smedile A
    Prog Clin Biol Res; 1987; 234():291-8. PubMed ID: 3628383
    [No Abstract]   [Full Text] [Related]  

  • 38. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract]   [Full Text] [Related]  

  • 39. Electron microscopic study of hepatitis B virus-associated antigens on the infected liver cell membrane in relation to analysis of immune target antigens in chronic hepatitis B.
    Saito T; Kamimura T; Ishibashi M; Shinzawa H; Takahashi T
    Gastroenterol Jpn; 1992 Dec; 27(6):734-44. PubMed ID: 1468605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Hepatology; 1991 Jun; 13(6):1052-6. PubMed ID: 2050321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.